OpenFilings
Theravance Biopharma, Inc.
Form
8-K
Report Period
2024-02-26
Date Filed
2024-02-26
Time Filed
16:16:00
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
FORM 8-K
EXHIBIT 99.1
EXHIBIT 99.2
Filing on SEC Edgar